Switch View
© PR Newswire
19.10.2025
ISIN: KYG1996C1006
CARsgen Therapeutics Holdings Limited
2171
LISTED
HKSE
Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia
News Preview
SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Primary plasma cell leukemia (pPCL) is a rare and highly aggressive plasma cell malignancy, often associated with complex genetic abnormalities. There is currently no standard treatment regimens, and conventional therapies for multiple myeloma are typically used. While targ...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
19.10.2025
ISIN: US60770K1079
Moderna, Inc
MRNA
LISTED
NASDAQ
Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025
News Preview
CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, October 19-22, 2025, in Atlanta, GA. The details of the presentations are as follows:Late-Breaking Oral...
Themefolio
Profiler
Peergroup
© BusinessWire
18.10.2025
ISIN: US24661P8077
Delcath Systems, Inc.
DCTH
LISTED
NASDAQ
Delcath Systems Announces Preliminary Third Quarter 2025 Financial Results
News Preview
Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today provided preliminary revenue and financial results for the quarter ended September 30, 2025, and updated 2025 full-year revenue guidance.
Preliminary Third Quarter Financial Results (unaudited)
Total...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
18.10.2025
ISIN: US24661P8077
Delcath Systems, Inc.
DCTH
LISTED
NASDAQ
Delcath Systems Announces Investigator-Initiated CHOPIN Clinical Trial Meets Primary Endpoint
News Preview
Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the results of the CHOPIN randomized Phase 2 clinical trial (CHOPIN Trial) presented by Principal Investigator and Lead Author Professor Ellen Kapiteijn, MD, from Leiden University Medical Cente...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
18.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
SMLR Deadline: SMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Semler Scientific, Inc. (NASD...
Themefolio
Profiler
Peergroup
© EQS Newswire
18.10.2025
ISIN: CA36118K1084
Future Fuels Inc.
FTUR
LISTED
TSX
Future Fuels erweitert geophysikalische Datengrundlage
News Preview
EQS-Media / 18.10.2025 / 18:35 CET/CEST
Future Fuels Inc. (ISIN: CA36118K1084 | WKN: A40TUW), Future Fuels oder das Unternehmen, freut sich bekannt zu geben, dass das Unternehmen das Phase-Eins-Gravitations-Explorationsprogramms auf seinem zu 100 % unternehmenseigenen Projekt “Hornby” abgeschlossen hat, das sich etwa 95 Kilometer südwestlich v......
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: CNE1000062J1
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
6990
LISTED
HKSE
Kelun-Biotech Presents Positive Results of Phase 3 Clinical Study OptiTROP-Breast02 for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer at 2025 ESMO
News Preview
CHENGDU, China, Oct. 18, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, results from a Phase 3 OptiTROP-Breast02 study of the Company's trophoblast cell-surface antigen...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: CNE1000062J1
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
6990
LISTED
HKSE
Kelun-Biotech Presents Positive Results of Phase 3 Clinical Study OptiTROP-Breast02 for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer at 2025 ESMO
News Preview
CHENGDU, China, Oct. 18, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, results from a Phase 3 OptiTROP-Breast02 study of the Company's trophoblast cell-surface antigen...
Themefolio
Profiler
Peergroup
© BusinessWire
18.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
KEYTRUDA® (pembrolizumab) Plus Chemotherapy With or Without Bevacizumab Reduced Risk of Disease Progression or Death Versus Chemotherapy With or Without Bevacizumab in Certain Patients With Platinum-Resistant Recurrent Ovarian Cancer
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first presentation of results from the pivotal Phase 3 KEYNOTE-B96 trial, also known as ENGOT-ov65, evaluating KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination with chemotherapy (paclitaxel) with or without bevacizumab for the treatment...
Themefolio
Profiler
Peergroup
© BusinessWire
18.10.2025
ISIN: US0463531089
AstraZeneca PLC
AZN
LISTED
NASDAQ
ENHERTU® (fam-trastuzumab deruxtecan-nxki) reduced the risk of disease recurrence or death by 53% vs. T-DM1 in patients with high-risk HER2-positive early breast cancer following neoadjuvant therapy in DESTINY-Breast05 Phase III trial
News Preview
Positive results from the DESTINY-Breast05 Phase III trial showed ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a highly statistically significant and clinically meaningful improvement in invasive disease-free survival (IDFS) in patients with a high risk of disease recurrence. The trial compared ENHERTU with trastuzumab emtansine (T-DM1)...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.10.2025
ISIN: US82655M1071
Sify Technologies Limited
SIFY
LISTED
NASDAQ
Sify Technologies to announce Financial Results for Second Quarter FY 2025-26 on Saturday, October 25, 2025
News Preview
CHENNAI, India, Oct. 18, 2025 (GLOBE NEWSWIRE) -- Sify Technologies Limited (NASDAQ: SIFY), India’s leading Digital ICT solutions provider with global service capabilities spanning Data Center, Cloud, Networks, Security and Digital services, today announced that it will report its unaudited IFRS financial results for the second quarter ended Sept...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US7170811035
Pfizer Inc
PFE
LISTED
NYSE
PADCEV™ Plus KEYTRUDA™, Given Before and After Surgery, Cuts the Risk of Recurrence, Progression or Death by 60% and the Risk of Death by 50% for Certain Patients with Bladder Cancer
News Preview
First and only combination regimen to improve survival when used before and after surgical cystectomy in cisplatin-ineligible patients with muscle-invasive bladder cancer
Unprecedented survival results from pivotal Phase 3 EV-303 trial...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
18.10.2025
ISIN: US0463531089
AstraZeneca PLC
AZN
LISTED
NASDAQ
ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery resulted in a pathologic complete response in 67% of patients with high-risk HER2-positive early-stage breast cancer in DESTINY-Breast11 Phase III trial
News Preview
Positive results from the DESTINY-Breast11 Phase III trial showed ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by paclitaxel, trastuzumab and pertuzumab (THP) in the neoadjuvant setting (before surgery) demonstrated a statistically significant and clinically meaningful improvement in the pathologic complete response (pCR) rate. The trial co...
Themefolio
Profiler
Peergroup
© BusinessWire
18.10.2025
ISIN: JP3475350009
Daiichi Sankyo Co Ltd
45680
LISTED
XJPX
ENHERTU® Followed by THP Before Surgery Resulted in a Pathologic Complete Response in 67% of Patients with High-Risk HER2 Positive Early-Stage Breast Cancer in DESTINY-Breast11 Phase 3 Trial
News Preview
Positive results from the DESTINY-Breast11 phase 3 trial showed ENHERTU® (trastuzumab deruxtecan) followed by paclitaxel, trastuzumab and pertuzumab (THP) in the neoadjuvant setting (before surgery) demonstrated a statistically significant and clinically meaningful improvement in the pathologic complete response (pCR) rate when compared with dose-...
Themefolio
Profiler
Peergroup
© BusinessWire
18.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Reduced Risk of Event-Free Survival Events by 60% and Risk of Death by 50% for Certain Patients with Muscle-Invasive Bladder Cancer When Given Before and After Surgery
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced landmark results demonstrating KEYTRUDA® (pembrolizumab) plus Padcev® (enfortumab vedotin-ejfv) reduced the risk of event-free survival (EFS) events by 60% and reduced the risk of death by 50% when given before and after surgery (radical cystectomy) versus sur...
Themefolio
Profiler
Peergroup
© BusinessWire
18.10.2025
ISIN: JP3475350009
Daiichi Sankyo Co Ltd
45680
LISTED
XJPX
ENHERTU® Reduced the Risk of Disease Recurrence or Death by 53% Versus T-DM1 in Patients with High-Risk HER2 Positive Early Breast Cancer Following Neoadjuvant Therapy in DESTINY-Breast05 Phase 3 Trial
News Preview
Positive results from the DESTINY-Breast05 phase 3 trial showed ENHERTU® (trastuzumab deruxtecan) demonstrated a highly statistically significant and clinically meaningful improvement in invasive disease-free survival (IDFS) compared to trastuzumab emtansine (T-DM1) as a post-neoadjuvant treatment (after surgery) in patients with HER2 positive ear...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: GB00BQH8G337
Rezolve AI Ltd
RZLV
LISTED
NASDAQ
Rezolve AI Investor News: Rosen Law Firm Encourages Rezolve AI plc Investors to Inquire About Securities Class Action Investigation - RZLV
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on beha...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US05380C1027
AVITA Medical Inc
RCEL
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AVITA Medical, Inc. ("Avita" or the "Company") (NASDAQ: RCEL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming Deadlines - CYTK
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Cytokinetics, Incorporate ("Cytokinetics" or the "Company") (NASDAQ: CYTK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-fr...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US1508701034
Celanese Corp
CE
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Celanese Corporation - CE
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Celanese Corporation ("Celanese" or the "Company") (NYSE: CE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: CA23256X4075
Cybin Inc.
CYBN
LISTED
XASE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cybin Inc. ("Cybin" or the "Company") (NYSE: CYBN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US83067L2088
Skillz Inc
SKLZ
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Skillz Inc.- SKLZ
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Skillz Inc. ("Skillz" or the "Company") (NYSE: SKLZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US9182041080
VF Corp
VFC
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in VF Corporation of Class Action Lawsuit and Upcoming Deadlines - VFC
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against VF Corporation ("VFC" or the "Company") (NYSE: VFC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US8716071076
Synopsys Inc
SNPS
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Synopsys, Inc. - SNPS
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Synopsys, Inc. ("Synopsys" or the "Company") (NASDAQ: SNPS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US83304A1060
Snap Inc
SNAP
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Snap, Inc. of Class Action Lawsuit and Upcoming Deadlines - SNAP
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Snap, Inc. ("Snap" or the "Company") (NYSE: SNAP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who in...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US2605571031
Dow Inc
DOW
LISTED
NYSE
Pomerantz Law Firm Announces the Filing of a Class Action Against Dow Inc. and Certain Officers - DOW
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Dow Inc. ("Dow" or the "Company") (NYSE: DOW) and certain officers. The class action, filed in the United States District Court for the Eastern District of Michigan, Northern Division, and docketed u...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US35671D8570
Freeport-McMoRan Inc
FCX
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Freeport-McMoran Inc. - FCX
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Freeport-McMoran Inc. ("Freeport" or the "Company") (NYSE: FCX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US7476191041
Quanex Building Products Corp
NX
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quanex Building Products Corporation of Class Action Lawsuit and Upcoming Deadlines - NX
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Quanex Building Products Corporation ("Quanex" or the "Company") (NYSE: NX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-fre...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US69380Q1076
PACS Group, Inc.
PACS
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PACS Group, Inc. - PACS
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PACS Group, Inc. ("PACS" or the "Company") (NYSE: PACS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US3439271095
Fly-E Group, Inc.
FLYE
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Fly-E Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - FLYE
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fly-E Group, Inc. ("Fly-E" or the "Company") (NASDAQ: FLYE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Th...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US5171251003
Larimar Therapeutics Inc
LRMR
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Larimar Therapeutics, Inc. ("Larimar" or the "Company") (NASDAQ: LRMR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US34960Q1094
Fortress Biotech, Inc.
FBIO
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fortress Biotech Inc. ("Fortress" or the "Company") (NASDAQ: FBIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US1431301027
Carmax Inc
KMX
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CarMax, Inc. - KMX
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CarMax, Inc. ("CarMax" or the "Company") (NYSE: KMX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US92937A1025
WPP plc
WPP
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in WPP Plc of Class Action Lawsuit and Upcoming Deadlines - WPP
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against WPP Plc ("WPP" or the "Company") (NYSE: WPP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US8753721047
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US64107N2062
Lesaka Technologies Inc
LSAK
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lesaka Technologies, Inc. - LSAK
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Lesaka Technologies, Inc. ("Lesaka" or the "Company") (NASDAQ: LSAK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US34959E1091
Fortinet Inc
FTNT
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Fortinet, Inc. of Class Action Lawsuit and Upcoming Deadlines - FTNT
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fortinet, Inc. ("Fortinet" or the "Company") (NASDAQ: FTNT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Th...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: FR0011472943
Valneva SE
VALN
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
News Preview
NEW YORK, Oct. 18, 2025/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Valneva SE ("Valneva" or the "Company") (NASDAQ: VALN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc. - DXCM
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: KYG0260P1028
Amer Sports, Inc.
AS
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amer Sports, Inc. - AS
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Amer Sports, Inc. ("Amer" or the "Company") (NYSE: AS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: GB00BMT7GT62
Marex Group PLC
MRX
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Marex Group Plc of Class Action Lawsuit and Upcoming Deadlines - MRX
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Marex Group Plc ("Marex" or the "Company") (NASDAQ: MRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US45769N1054
Innovative Solutions and Support, Inc.
ISSC
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Innovative Solutions and Support, Inc. - ISSC
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Innovative Solutions and Support, Inc. ("IS&S" or the "Company") (NASDAQ: ISSC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. ...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: GB00BJT16S69
Tronox Holdings PLC
TROX
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Tronox Holdings Plc of Class Action Lawsuit and Upcoming Deadlines - TROX
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Tronox Holdings Plc ("Tronox" or the "Company") (NYSE: TROX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. T...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US15673X2009
Cepton, Inc.
CPTN
LISTED
NASDAQ
Pomerantz Law Firm Announces the Filing of a Class Action Against Cepton, Inc. and Certain Officers - CPTN
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Cepton, Inc. ("Cepton" or the "Company") (NASDAQ: CPTN) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 2...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in aTyr Pharma, Inc. of Class Action Lawsuit and Upcoming Deadlines - ATYR
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ: ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Tho...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US58450V1044
Mediaalpha Inc
MAX
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MediaAlpha, Inc. - MAX
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of MediaAlpha, Inc. ("MediaAlpha" or the "Company") (NYSE: MAX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US74934Q1085
RCI Hospitality Holdings Inc
RICK
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RCI Hospitality Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - RICK
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against RCI Hospitality Holdings, Inc. ("RCI" or the "Company") (NASDAQ: RICK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ex...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US4052171000
Hain Celestial Group Inc
HAIN
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Hain Celestial Group, Inc. - HAIN
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Hain Celestial Group, Inc. ("Hain" or the "Company") (NASDAQ: HAIN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US1055321053
Braskem S.A.
BAK
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Braskem S.A. - BAK
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Braskem S.A. ("Braskem" or the "Company") (NYSE: BAK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US19247G1076
Coherent Corp
COHR
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Coherent Corp. - COHR
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Coherent Corp. ("Coherent" or the "Company") (NYSE: COHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in LifeMD, Inc. of Class Action Lawsuit and Upcoming Deadlines - LFMD
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US7479066000
Quantum Corp
QMCO
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Corporation of Class Action Lawsuit and Upcoming Deadlines - QMCO
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Quantum Corporation ("Quantum" or the "Company")(NASDAQ: QMCO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US3434121022
Fluor Corp
FLR
LISTED
NYSE
Pomerantz Law Firm Announces the Filing of a Class Action Against Fluor Corporation and Certain Officers - FLR
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fluor Corporation ("Fluor" or the "Company") (NYSE: FLR) and certain officers. The class action, filed in the United States District Court for the Northern District of Texas, Dallas Division, and doc...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US26853E1029
EHang Holdings
EH
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EHang Holdings Limited - EH
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of EHang Holdings Limited ("EHang" or the "Company") (NASDAQ: EH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US4718711033
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain Officers - JSPR
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ: JSPR) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and doc...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US12468P1049
C3.ai Inc
AI
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in C3.ai, Inc. of Class Action Lawsuit and Upcoming Deadlines - AI
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against C3.ai, Inc. ("C3" or the "Company") (NYSE: AI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inqui...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US0162551016
Align Technology, Inc.
ALGN
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Align Technology, Inc. - ALGN
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Align Technology, Inc. ("Align" or the "Company") (NASDAQ: ALGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. ...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US05463X1063
AxoGen Inc
AXGN
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Axogen, Inc. ("Axogen" or the "Company") (NASDAQ: AXGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US86627R1023
Summit Therapeutics Inc
SMMT
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Summit Therapeutics Inc. ("Summit" or the "Company") (NASDAQ: SMMT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2025
ISIN: US00847X1046
Agios Pharmaceuticals Inc
AGIO
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
News Preview
NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. ("Agios" or the "Company") (NASDAQ: AGIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. ...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
